中国住院患者血糖管理状况及应对策略  

Management and Strategy of Hyperglycemia in Hospitalized Patients

作　　者：李光伟[1] LI Guang-wei(Center of Endocrinology and Cardiovascular Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Beijing 100037, China)

机构地区：[1]中国医学科学院阜外心血管病医院内分泌与心血管病诊治中心,北京100037

出　　处：《药品评价》2017年第13期5-8,共4页Drug Evaluation

摘　　要：住院患者高血糖是指患者住院期间任意时间点的血糖水平>7.8mmol/L,患者可合并或不合并糖尿病。我国住院患者高血糖发生率较高。无论是否合并糖尿病,住院高血糖患者较血糖正常患者的住院时间、总住院费用和死亡率均较高。尽管各科高血糖患者占科室住院人数的比例逐年增加,然而,住院患者高血糖状态并未得到很好地控制。因此,应建立以内分泌科为主导的血糖管理的模式,对全院患者进行血糖管理。根据患者的情况,确定患者的血糖控制目标,制定适合患者的个体化治疗方案,选择合适的降糖药物,积极有效地管理住院患者的血糖。Hyperglycemia of in patients refers to plasma glucose level is more than7.8mmol/L at any time during hospitalization,thepatients could be diabetes mellitus or not.In China,the prevalence of hyperglycemia in hospitalized patients is high.Hyperglycemiaisassociated with longer hospital duration,higher total cost and higher morality.The proportion of patients with hyperglycemiainhospital increases year by year,however,the hyperglycemia in hospitalized patients has not been well controlled.Thus a group leadby endocrinology department,should be set up to manage in-hospital hyperglycemia.We should set individualized target and giveappropriate treatment for patients.

关 键 词：住院患者高血糖 胰岛素 血糖控制 内分泌科 

分 类 号：R587.1[医药卫生—内分泌]